U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186244) titled 'Prevention ICONA Dedicated Ensemble' on Aug. 04.
Brief Summary: Despite significant advances in HIV treatment, transmission remains a public health concern. In 2022, there were 1.3 million new HIV infections worldwide and 1,888 new diagnoses in Italy, with sexual transmission being the predominant route. Many individuals are still diagnosed late, and a portion of people living with HIV are unaware of their status. Pre-Exposure Prophylaxis (PrEP) has emerged as an effective biomedical strategy to prevent new infections, especially when integrated into comprehensive prevention efforts.
Study Objectives The primary objective of this ...